1539-1612/asset/olbannerleft.jpg?v=1&s=b3f2157bd7aaef490b616207a089ae32159b3a46)
1539-1612/asset/olbannerright.jpg?v=1&s=1c0d39d668c2e781107975b035cd3bee9047931d)
Main Paper
Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
Article first published online: 24 FEB 2010
DOI: 10.1002/pst.417
Copyright © 2010 John Wiley & Sons, Ltd.
Additional Information
How to Cite
Matcham, J., Julious, S., Pyke, S., O'Kelly, M., Todd, S., Seldrup, J. and Day, S. (2011), Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Pharmaceut. Statist., 10: 70–73. doi: 10.1002/pst.417
Publication History
- Issue published online: 24 FEB 2010
- Article first published online: 24 FEB 2010
- Abstract
- Article
- References
- Cited By
Keywords:
- trial reports;
- trial protocols;
- publication;
- authorship;
- clinical trial registration
Abstract
In this paper we set out what we consider to be a set of best practices for statisticians in the reporting of pharmaceutical industry-sponsored clinical trials. We make eight recommendations covering: author responsibilities and recognition; publication timing; conflicts of interest; freedom to act; full author access to data; trial registration and independent review. These recommendations are made in the context of the prominent role played by statisticians in the design, conduct, analysis and reporting of pharmaceutical sponsored trials and the perception of the reporting of these trials in the wider community. Copyright © 2010 John Wiley & Sons, Ltd.